PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Ikerbasque, Basque Foundation for Science, Bilbao, Spain. virginia.arechavalagomeza@osakidetza.eus.\', \'Neuromuscular Disorders Research Group, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain. virginia.arechavalagomeza@osakidetza.eus.\', \'Department of Paediatrics, Amalia Children\'s hospital, Nijmegen, The Netherlands. Alex.Garanto@radboudumc.nl.\', \'Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands. Alex.Garanto@radboudumc.nl.\', \'Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University Medical Center, Nijmegen, The Netherlands. Alex.Garanto@radboudumc.nl.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/978-1-0716-2010-6_2
?:hasPublicationType
?:journal
  • Methods in molecular biology (Clifton, N.J.)
is ?:pmid of
?:pmid
?:pmid
  • 35213008
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.616
?:rankingScore_hIndex
  • 117
is ?:relation_isRelatedTo_publication of
?:title
  • Antisense RNA Therapeutics: A Brief Overview.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35213008>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35213008>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all